Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

NCT06349642 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06349642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
April 24, 2024
Completion date
May 31, 2027
Enrollment
324 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

early stage lung non-small cell carcinoma, early stage triple-negative breast carcinoma, metastatic bladder urothelial carcinoma, metastatic cervical carcinoma, metastatic clear cell renal cell carcinoma, metastatic colorectal carcinoma, metastatic endometrial carcinoma, metastatic esophageal carcinoma, metastatic liver carcinoma, metastatic lung non-small cell carcinoma, metastatic malignant skin neoplasm, metastatic malignant solid neoplasm, recurrent cervical carcinoma, recurrent colorectal carcinoma, recurrent endometrial carcinoma, recurrent esophageal carcinoma, recurrent liver carcinoma, recurrent lung non-small cell carcinoma, recurrent malignant skin neoplasm, recurrent malignant solid neoplasm, resectable lung non-small cell carcinoma, resectable malignant solid neoplasm, resectable triple-negative breast carcinoma, stage iii renal cell cancer ajcc v8, stage iv cervical cancer ajcc v8, stage iv renal cell cancer ajcc v8, stage iv uterine corpus carcinoma or carcinosarcoma ajcc v8